| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.20997 |
| P698 | PubMed publication ID | 17630645 |
| P50 | author | Nicola Volpi | Q39485241 |
| P2093 | author name string | Nicola Volpi | |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3168-3180 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Analytical aspects of pharmaceutical grade chondroitin sulfates | |
| P478 | volume | 96 |
| Q89865355 | A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients |
| Q53625004 | Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection. |
| Q37951364 | Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule |
| Q46491045 | Characterization of oversulfated chondroitin sulfate rich in 4,6-O-disulfated disaccharides in breast cyst fluids collected from human breast gross cysts |
| Q64253125 | Chondroitin Sulfate Safety and Quality |
| Q34655436 | Chondroitin and glucosamine in the management of osteoarthritis: an update |
| Q38838064 | Chondroitin sulphate: a focus on osteoarthritis |
| Q35634428 | Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits |
| Q33920880 | Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal |
| Q38371965 | Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. |
| Q62716232 | Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects |
| Q92462051 | Glycosaminoglycans from Co-Products of «Scyliorhinus canicula»: Extraction and Purification in Reference to the European Pharmacopoeia Requirement |
| Q51135134 | Glycosaminoglycans from chicken muscular stomach or gizzard. |
| Q47862778 | Glycosylation of DMP1 Is Essential for Chondrogenesis of Condylar Cartilage |
| Q84950953 | High-performance CE of Escherichia coli K4 cell surface polysaccharides |
| Q51830973 | Identification of chondroitin-like molecules from biofilm isolates Exiguobacterium indicum A11 and Lysinibacillus sp. C13. |
| Q37310621 | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate |
| Q44118071 | Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique |
| Q47816389 | Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). |
| Q39083233 | Medical application of glycosaminoglycans: a review |
| Q33633113 | Modern developments in mass spectrometry of chondroitin and dermatan sulfate glycosaminoglycans |
| Q102057573 | Molecular Changes in Dengue Envelope Protein Domain III upon Interaction with Glycosaminoglycans |
| Q54326036 | Monosaccharide precursors for boosting chondroitin-like capsular polysaccharide production. |
| Q90439510 | Oral Bioavailability and Pharmacokinetics of Nonanimal Chondroitin Sulfate and Its Constituents in Healthy Male Volunteers |
| Q34112904 | Pharmacoproteomic study of three different chondroitin sulfate compounds on intracellular and extracellular human chondrocyte proteomes |
| Q36433407 | Plasmatic and Urinary Glycosaminoglycans Characterization in Mucopolysaccharidosis II Patient Treated with Enzyme-Replacement Therapy with Idursulfase |
| Q39018675 | Purification and sequence characterization of chondroitin sulfate and dermatan sulfate from fishes |
| Q37611121 | Quality of different chondroitin sulfate preparations in relation to their therapeutic activity |
| Q33851507 | Systematic Analysis of Pharmaceutical Preparations of Chondroitin Sulfate Combined with Glucosamine |
| Q37820688 | The quality of commercially available nutraceutical supplements and food sources |
Search more.